LGD-4033

LGD (Ligandrol) was developed for the treatment of muscle wasting conditions, such as aging, osteoporosis, muscular dystrophy and cancer.  Muscle wasting, including a loss of skeletal muscle, is a cancer-related symptom that begins early in the progression of cancer and affects a patient’s quality of life, ability to tolerate chemotherapy, and survival. In addition to legitimate medical uses, it is also being used as a performance-enhancing drug. In the body-building world, LGD is being promoted as a side-effect free alternative to steroids, such as testosterone, to increase lean muscle mass and athletic performance. The drug is popular with a wide range of athletes and professionals who are conscious of their muscle size and body composition, including weight lifters, bodybuilders, models, crossfitters, athletes and strongmen.